CHIC1
Cysteine-rich hydrophobic domain-containing protein 1
Also known as: BRX, CHIC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VXU3
- Gene
- CHIC1
- Ensembl
- ENSG00000204116
- Chromosome
- X
- Canonical length
- 224 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nuclear speckles,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a cysteine-rich hydrophobic (CHIC) domain-containing protein, and is one of the few protein-coding genes found near the X-inactivation center. Studies in mouse indicate that the mouse ortholog of this gene is subject to X-inactivation in mouse. Experiments with other CHIC domain-containing family members show that the cysteine residues are palmitoylated post-translationally, resulting in membrane association. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
224 residues, UniProt reviewed canonical sequence.
>Q5VXU3|CHIC1
1 MSILLPNMAE FDTISELEEE EEEEAATSSS SPSSSSSVSG PDDDEEDEEE EEEEEEEEEE
61 EEEEEEEEAP PPPRVVSEEH LRRYAPDPVL VRGAGHITVF GLSNKFDTEF PSVLTGKVAP
121 EEFKTSIGRV NACLKKALPV NVKWLLCGCL CCCCTLGCSL WPVICLNKRT RRSIQKLIEW
181 ENNRLYHKLA LHWKLTKRKC ETSNMMEYVI LIEFLPKYPI FRPDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHIC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 8 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 8 nTPM
- cerebellum: 7.2 nTPM
- hypothalamus: 6.5 nTPM
- adrenal gland: 6.4 nTPM
- cervix: 6.4 nTPM
- spinal cord: 6 nTPM
Single-cell type
- somatotrophs: 146 nCPM
- thyrotrophs: 143 nCPM
- lactotrophs: 134 nCPM
- corticotrophs: 117 nCPM
- bergmann glia: 115 nCPM
- pituicytes/fscs: 110 nCPM
Immune cell
- MAIT T-cell: 0.7 nTPM
- gdT-cell: 0.4 nTPM
- memory CD8 T-cell: 0.4 nTPM
- naive CD8 T-cell: 0.4 nTPM
- memory CD4 T-cell: 0.3 nTPM
- naive CD4 T-cell: 0.3 nTPM
Brain region
- cerebral cortex: 20 nTPM
- hypothalamus: 18 nTPM
- pons: 17 nTPM
- thalamus: 17 nTPM
- medulla oblongata: 16 nTPM
- spinal cord: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHIC1.
Disease | ImmuneIEDB
Conditions an epitope on CHIC1 was assayed in.
- Chagas disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHIC1 as an antibody target. Whether an autoantibody or antibody against CHIC1 could matter depends on whether native CHIC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHIC1 is annotated at the cell surface, where native CHIC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CHIC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...